Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development

por Kähkönen, Tiina E., Halleen, Jussi M., Bernoulli, Jenni
Publicado 2020

Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis

por Kähkönen, Tiina E., Halleen, Jussi M., Bernoulli, Jenni
Publicado 2021

Insights into immuno-oncology drug development landscape with focus on bone metastasis

por Kähkönen, Tiina E., Halleen, Jussi M., MacRitchie, Gary, Andersson, Ronnie M., Bernoulli, Jenni
Publicado 2023

Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model

por Kähkönen, Tiina E., Tuomela, Johanna M., Grönroos, Tove J., Halleen, Jussi M., Ivaska, Kaisa K., Härkönen, Pirkko L.
Publicado 2019

Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone

por Kähkönen, Tiina E., Suominen, Mari I., Mäki-Jouppila, Jenni H. E., Halleen, Jussi M., Tanaka, Azusa, Seiler, Michael, Bernoulli, Jenni
Publicado 2019

Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio

por Luukkonen, Jani, Pascual, Laia Mira, Patlaka, Christina, Lång, Pernilla, Turunen, Sanna, Halleen, Jussi, Nousiainen, Tomi, Valkealahti, Maarit, Tuukkanen, Juha, Andersson, Göran, Lehenkari, Petri
Publicado 2017